The landscape of diabetes care is advancing with the arrival of transdermal GLP-1 delivery . These innovative devices offer a possibly more comfortable alternative to shots for individuals managing diabetes 2. Such a system deliver GLP-1 medication directly through the epidermis, circumventing the need for frequent injections and potentially improv